E-ISSN 2636-834X
 
2024, Vol: 14, Issue: 1
14 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

COPYRIGHT FORM
_Title_Page_Obligatory_(v2r)_

Case Report 


Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.

Esra Okyar , Leyla Bozatlı, Işık Görker.


Abstract
Fragile X Syndrome is a genetic disease defined by cognitive and behavioral characteristics that accompany apparent physical features. Male individuals are affected by this syndrome more severely, and it is the most common cause of mental retardation in men. The most common accompanying psychiatric conditions are mental retardation, autism, Attention Deficit Hyperactivity Disorder (ADHD), anxiety disorder, depression, sleep disorders and aggression. Anxiety, depression, shyness and social withdrawal are more common in female individuals. The diagnosis and treatment of the ADHD and selective mutism in a female adolescent patient who was Fragile X full mutant will be discussed in this case report.

Key words: Fragile X syndrome, ADHD, atomoxetine.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Esra Okyar
Articles by Leyla Bozatlı
Articles by Işık Görker
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

EO, Bozatlı L, Gorker I, . Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS. 2019; 9(4): 195-197. doi:10.5455/PBS.20190128114451

Web Style

EO, Bozatlı L, Gorker I, . Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. https://www.pbsciences.org/?mno=28313 [Access: April 08, 2024]. doi:10.5455/PBS.20190128114451

AMA (American Medical Association) Style

EO, Bozatlı L, Gorker I, . Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS. 2019; 9(4): 195-197. doi:10.5455/PBS.20190128114451


Vancouver/ICMJE Style

EO, Bozatlı L, Gorker I, . Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS. (2019), [cited April 08, 2024]; 9(4): 195-197. doi:10.5455/PBS.20190128114451


Harvard Style

, E. O. ., Bozatlı, L. . ., Gorker, I. . . & (2019) Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS, 9 (4), 195-197. doi:10.5455/PBS.20190128114451


Turabian Style

, Esra Okyar , Leyla Bozatlı, Işık Gorker, and . 2019. Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. Psychiatry and Behavioral Sciences, 9 (4), 195-197. doi:10.5455/PBS.20190128114451


Chicago Style

, Esra Okyar , Leyla Bozatlı, Işık Gorker, and . "Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.." Psychiatry and Behavioral Sciences 9 (2019), 195-197. doi:10.5455/PBS.20190128114451


MLA (The Modern Language Association) Style

, Esra Okyar , Leyla Bozatlı, Işık Gorker, and . "Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.." Psychiatry and Behavioral Sciences 9.4 (2019), 195-197. Print. doi:10.5455/PBS.20190128114451


APA (American Psychological Association) Style

, E. O. ., Bozatlı, L. . ., Gorker, I. . . & (2019) Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. Psychiatry and Behavioral Sciences, 9 (4), 195-197. doi:10.5455/PBS.20190128114451


Author LoginReviewer Login

About Psychiatry and Behavioral Sciences

Psychiatry and Behavioral Sciences is a scientific journal currently published by Turkish Association for Psychopharmacology.  It has been published as ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Editor in Chief

Prof. Dr. Mesut ÇETİN
Address: Bagdat Cad. Birgen Is Merkezi 226/7 Kadikoy - Istanbul - TURKEY 34728Phone:+90 (532) 272 32 52E-mail:psikofarmakoloji@gmail.com